Tuesday, March 17, 2026

Trump’s New Defense Strategy: Why Seoul Is Expected to Lead Deterrence as 28,500 U.S. Troops Stay Put

The new U.S. National Defense Strategy emphasizes South Korea's military capabilities and shifts responsibilities in countering North Korea.

Diplomacy and Unification Ministries Again at Odds Over ‘North Korea Policy Consultation’… Unexpected Internal ROK Conflict

South Korea's Unification Ministry and Foreign Ministry clash over North Korea policy consultations, highlighting internal government disagreements.

Huang: U.S. AI Edge Over China Is Barely Hanging On

Nvidia CEO Jensen Huang warns China's AI capabilities are catching up to the U.S., urging policy changes to boost domestic tech development.

Tag: pharmacokinetics

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.